Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2000
02/10/2000WO2000006723A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines
02/10/2000WO2000006722A1 Eukaryotic cell-based gene interaction cloning
02/10/2000WO2000006721A1 Serological diagnosis of protostrongylidae infections and identification of unique antigens
02/10/2000WO2000006720A1 A novel regulatory molecule and genetic sequences encoding same
02/10/2000WO2000006719A1 Nucleic acids encoding proteins involved in sensory transduction
02/10/2000WO2000006717A2 Improved transformation efficiency in phage display through modification of a coat protein
02/10/2000WO2000006716A1 Growth differentiation factor-11
02/10/2000WO2000006714A1 DDKh-3 NUCLEIC ACIDS, POLYPEPTIDES, VECTORS, HOST CELLS, METHODS AND USES THEREOF
02/10/2000WO2000006713A2 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
02/10/2000WO2000006699A1 Novel molecules of the tango-175-related protein family and uses thereof
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy
02/10/2000WO2000006605A2 Heterominibodies
02/10/2000WO2000006603A1 Antibody for detecting microorganism
02/10/2000WO2000006602A1 Cancer antigens based on tumor suppressor gene wt1 product
02/10/2000WO2000006601A1 Isoforms of human calcium sensing receptor
02/10/2000WO2000006600A1 Human mink gene mutations associated with arrhythmia
02/10/2000WO2000006599A1 Inhibitors of hiv membrane fusion
02/10/2000WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens
02/10/2000WO2000006596A2 Interferon alpha hybrids
02/10/2000WO2000006595A1 Hla-a2 restraint tumor antigen peptide originating in sart-1
02/10/2000WO2000006593A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006592A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006591A2 Adap nucleic acids, polypeptides, vectors, host cells, methods and uses thereof
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000WO2000006199A1 Kvlqt1 - a long qt syndrome gene
02/10/2000WO2000006195A1 Targeting pharmaceutical agents to injured tissues
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000006185A2 Methods of using lanreotide, a somatostatin analogue
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006087A2 Uncoupling protein-2(hcp2): compositions and methods of use
02/10/2000WO2000001729A3 Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
02/10/2000WO2000000829A3 Method and composition to detect c-type retroviral infection
02/10/2000WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens
02/10/2000WO2000000598A3 Plant dwarfing
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999067356A3 Propionibacterium vector
02/10/2000WO1999066074A8 Vibrio vulnificus molecular probes, antibodies, and proteins
02/10/2000WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use
02/10/2000WO1999064603A3 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
02/10/2000WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/10/2000WO1999058674A3 Method of inhibiting osteoclast activity
02/10/2000WO1999058557A3 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof
02/10/2000WO1999058142A9 Use of anti-prolactin agents to treat proliferative conditions
02/10/2000WO1999049045A3 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort)
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000WO1999045116A3 Human homolog of a nuclear migration gene and its use
02/10/2000WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000WO1999024580A3 Essential fungal genes and their use
02/10/2000DE19840771A1 A thermostable in vitro polymerase complex for template-dependent elongation of nucleic acids in amplification or reverse transcription methods
02/10/2000CA2776054A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000CA2340855A1 Granulocytic ehrlichia genes and uses thereof
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2338022A1 Inhibitors of hiv membrane fusion
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2337743A1 Tumor antigen based on products of the tumor suppressor gene wt1
02/10/2000CA2337692A1 Kdel receptor inhibitors
02/10/2000CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
02/10/2000CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337492A1 Delta-related polypeptides
02/10/2000CA2337102A1 Nucleic acids and proteins from group b streptococcus
02/10/2000CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337086A1 Eukaryotic cell-based gene interaction cloning
02/10/2000CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2336536A1 Growth differentiation factor-11
02/10/2000CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000CA2336486A1 Hla-a2 restricted tumor antigen peptide originated from sart-1
02/10/2000CA2336263A1 Kvlqt1 - a long qt syndrome
02/10/2000CA2336222A1 Serological diagnosis of protostrongylidae infections and identification of unique antigens
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335654A1 Methods of using a somatostatin analogue
02/10/2000CA2335644A1 Phosphorylation effectors
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
02/10/2000CA2335376A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000CA2335320A1 Nucleic acids encoding proteins involved in sensory transduction
02/10/2000CA2335228A1 Human epidermal proteins hepi-1 to hepi-6
02/10/2000CA2334170A1 Improved transformation efficiency in phage display through modification of a coat protein
02/10/2000CA2240611A1 Recombinant sendai virus vector expressing chemokine
02/09/2000EP0978570A2 Detecting mycobacterium tuberculosis by nucleic acid sequence amplification
02/09/2000EP0978566A2 Chimaeric adenoviruses
02/09/2000EP0978565A1 Process for producing peptide with the use of accessory peptide
02/09/2000EP0978564A1 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
02/09/2000EP0978562A1 Calcium/calmodulin dependent kinase and alternative splice product thereof
02/09/2000EP0978519A1 Transcriptional regulator
02/09/2000EP0977993A1 Cadherin-11 as an indicator of viable pregnancy
02/09/2000EP0977991A1 Monoclonal antibodies to human cd6
02/09/2000EP0977895A1 Stealth virus nucleic acids and related methods
02/09/2000EP0977893A1 Reagents and methods useful for detecting diseases of the prostate
02/09/2000EP0977887A2 Member of the tnf family useful for treatment and diagnosis of disease
02/09/2000EP0977886A1 Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
02/09/2000EP0977881A1 Expression of a modified foamy virus envelope protein